Automating Alternatives Across a Formulary

 
Automating Alternatives Across a Formulary.png
 

Formulary and Benefit (F&B) data and Real-Time Pharmacy Benefit inquiries (RTPB) are a powerful combination that health plans and other payers can use to communicate preferred alternatives to prescribers through electronic health records (EHRs).

Currently, finding alternatives to high tier, non-preferred, non-formulary and uncovered drugs is a cumbersome, trial-and-error process that costs health plans, prescribers, pharmacists and patients time and money. Even among generics there can be large price variations. Formulary creators who must manually choose the best alternatives face a daunting task that requires ongoing maintenance and review.

By automating the delivery of preferred alternatives through existing EHR capabilities, payers can increase the use of preferred drugs, decrease prescription costs, and save prescribers time. BenMedica’s SmartAlts™ provides a cost-effective solution for establishing and updating formulary alternatives.

Alternatives using Real-Time Pharmacy Benefit Inquiries

In an earlier post we discussed using F&B data to communicate drug alternatives to prescribers in their EHR at the time of prescribing. RTPB transactions are another option prescribers can use when identifying alternatives.

RTPBs are a growing part of the market as more EHRs integrate this capability. We expect adoption of RTPBs to accelerate significantly once NCPDP (an ANSI-accredited Standards Development Organization (SDO), that uses a consensus-building process to create national standards for real-time, electronic exchange of healthcare information.) completes the development of its standard. This standard is likely to be adopted at a federal level.

While RTPBs are an important capability within the EHR, they are not the optimal way for prescribers to determine alternatives. RTPBs require the prescriber to write the preponderance of a prescription’s details before returning patient out-of-pocket information such as copays and deductibles as well as potential drug alternatives. Using RTPB, the prescriber may not know if there are a less expensive but suitable alternatives until the initial prescription is almost completely written.

Reliance on RTPBs to find alternatives also wastes time. While RTPB is a quick transaction to process, the steps involved (picking a pharmacy, selecting a drug, creating a Sig, calculating a quantity, and determining refills) each take some time. This problem compounds if prescribers must write multiple prescriptions to find one that is both affordable and effective. As one physician noted in our recent EHR roundtable, “I typically write 2 to 3 scripts per patient encounter and have 30-40 appointments each day. To have to review each script would make me want to turn it off. I don’t have time for this.”

Overcoming the Hurdles to Providing Actionable Alternatives

We have found that many health plans do not leverage the capabilities of F&B data and RTPBs to provide alternatives. This leaves prescribers without critical information on alternatives and patients stuck paying more for prescriptions or abandoning them altogether.

We have evaluated a number of alternative drug creation options to create a proprietary methodology for avoiding pitfalls in current alternative methods. Some common problems we have found:

  1. Therapeutic alternatives are too wide and may not be relevant for the non-formulary drug

  2. Alternatives show other versions of the same product that aren’t less expensive

  3. Alternatives include generics that are not relevant as prescribers typically have a generics-first protocol

  4. Alternative options aren’t displayed by equivalent strengths and doses causing physician confusion

BenMedica SmartAlts

SmartAlts are curated lists of therapeutic drug alternatives that can be used in a variety of applications including patient or provider-facing web tools, prescribing systems, and mail campaigns.

BenMedica has developed a proprietary process to create and update formulary alternative drug listings using clinical evidence found in published primary research, reference textbooks, structured reviews, and expert opinion. This provides a more succinct list of clinically-informed alternatives than those found in compendia or standard drug database therapeutic classes.

When paired with formulary status and pricing information, this smaller, more targeted drug alternative list provides end-users with alternatives to their currently selected drugs that are less costly but perform similarly.

Selecting lower-cost alternatives reduces pharmacy costs, saves patients money, and increases the use of preferred medications.

BenMedica’s Experience

BenMedica has successfully assisted health plans in developing alternatives for use by prescribers in EHRs. Automating the creation of SmartAlts alternatives based on current formulary and benefit data offers reliable communications with relevant information to prescribers. With formulary and benefit data, health plans can use an existing feed to communicate to prescribers.

With deep experience developing processes to best leverage existing data, BenMedica helps health plans reach prescribers at the time of ePrescribing. Contact us to learn more.